79481-0502 NDC - SINUS WASH SALINE REFILLS (SODIUM BICARBONATE, SODIUM CHLORIDE)

Drug Information

Product NDC: 79481-0502

Proprietary Name: Sinus Wash Saline Refills

Non Proprietary Name: SODIUM BICARBONATE, SODIUM CHLORIDE

Active Ingredient(s):
  • 700 mg/3000mg SODIUM BICARBONATE;
  • 2300 mg/3000mg SODIUM CHLORIDE


Administration Route(s): NASAL

Dosage Form(s): POWDER, FOR SOLUTION

Pharmacy Class(es):
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC]

Labeler Information

Labeler Name: Meijer, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date:1/8/2022

Package Information

No. Package Code Package Description Billing Unit
179481-0502-2100 PACKET in 1 CARTON (79481-0502-2) / 3000 mg in 1 PACKET

NDC Record

Field Name Field Value Definition
PRODUCT NDC79481-0502The translation of the dosage form Code submitted by the firm.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMESinus Wash Saline RefillsThis is the date that the labeler indicates was the start of its marketing of the drug product.
PROPRIETARY NAME SUFFIXMeijerProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
NON PROPRIETARY NAMESODIUM BICARBONATE, SODIUM CHLORIDEThis corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
DOSAGE FORM NAMEPOWDER, FOR SOLUTIONName of Company corresponding to the labeler code segment of the Product NDC.
ROUTE NAMENASALAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
START MARKETING DATE1/8/2022This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED DRUG OTHERProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEMeijer, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMESODIUM BICARBONATE; SODIUM CHLORIDEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH700; 2300 
ACTIVE INGRED UNITmg/3000mg; mg/3000mg 
PHARM CLASSESIncreased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023